LERCADIP lercanidipine hydrochloride 20 mg tablet blister pack

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

lercanidipine hydrochloride

Disponibbli minn:

Mylan Health Pty Ltd

INN (Isem Internazzjonali):

Lercanidipine hydrochloride

L-istatus ta 'awtorizzazzjoni:

Registered

Fuljett ta 'informazzjoni

LERCADIP
_Lercanidipine hydrochloride_
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some of the
common questions about Lercadip. It
does not contain all the available
information. It does not replace
seeking advice from your doctor or
pharmacist.
PLEASE READ THIS LEAFLET BEFORE YOU
START TAKING LERCADIP.
If you are helping someone else take
Lercadip, please read this leaflet
before you give the first dose.
All medicines have risks and
benefits. Your doctor has weighed
the risks of you taking Lercadip
against the benefits this medicine is
expected to have for you.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT LERCADIP IS USED
FOR
The name of your medicine is
Lercadip, which is also known as
lercanidipine. Lercadip belongs to a
group of medicines called calcium
channel blockers (of the
dihydropyridine group).
Lercadip lowers high blood pressure,
which doctors call hypertension. It
works by relaxing some of the blood
vessels in the body and reducing
resistance to the flow of blood
through the blood vessels.
Everyone has blood pressure. This
pressure helps get your blood all
around your body. Your blood
pressure may be different at different
times of the day, depending on how
busy or worried you are. You have
hypertension (high blood pressure)
when your blood pressure stays
higher than is needed, even when you
are calm and relaxed.
There are usually no symptoms of
hypertension. The only way of
knowing that you have hypertension
is to have your blood pressure
checked on a regular basis. If high
blood pressure is not treated it can
lead to serious health problems. You
may feel fine and have no symptoms,
but eventually hypertension can
cause stroke, heart disease and
kidney failure. Lercadip helps lower
your blood pressure.
Lercadip cannot be obtained without
a doctor's prescription.
There is no evidence that Lercadip is
addictive.
BEFORE YOU TAKE
LERCADIP
_WHEN YOU MUST NOT TAKE I

Karatteristiċi tal-prodott

AUSTRALIAN PRODUCT INFORMATION
LERCADIP
_Lercanidipine hydrochloride tablets _
1
NAME OF THE MEDICINE
Lercanidipine hydrochloride
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Lercanidipine hydrochloride is a microcrystalline, odourless, citrine
powder.
Each Lercadip 10 mg tablet contains 9.4 mg of lercanidipine (present
as lercanidipine hydrochloride 10 mg)
as the active ingredient.
Each Lercadip 20 mg tablet contains 18.8 mg of lercanidipine (present
as lercanidipine hydrochloride 20 mg)
as the active ingredient.
Excipients with known effect: Lercadip also contains lactose, see
SECTION 4.4 - SPECIAL
WARNINGS AND
PRECAUTIONS FOR USE
.
For the full list of excipients, see
SECTION 6.1 - LIST OF EXCIPIENTS
.
3
PHARMACEUTICAL FORM
Lercadip 10 mg tablet is available as a yellow, round, scored,
film-coated tablet.
Lercadip 20 mg tablet is available as a pink, circular, biconvex,
film-coated tablets.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Lercadip is indicated for the treatment of hypertension.
4.2
DOSE AND METHOD OF ADMINISTRATION
The recommended dose is 10 mg once daily, at least 15 minutes before a
meal. The dose may be increased to
20 mg once daily depending on the individual response. Dose titration
should be gradual, as it may take about
2 weeks for the maximal antihypertensive effect to be apparent.
Titration may proceed more rapidly, however,
if clinically warranted, provided the patient is assessed frequently.
Since it is unlikely that increasing the dose
beyond 20 mg will further improve the efficacy, and may be associated
with side effects, doses above 20 mg
are not recommended. Some individuals not adequately controlled on a
single antihypertensive agent may
benefit from the addition of lercanidipine at the same doses used in
monotherapy to the existing regimen with
a beta-blocker, a diuretic or an ACE inhibitor.
Use in elderly, children, hepatic and renal impairment: see
SECTION 4.4 - SPECIAL WARNINGS AND PRECAUTIONS
FOR USE
.
4.3
CONTRAINDICATIONS
•
Hypersensitivity to any dihydropyridine or an